CD8A and atherosclerosis: In a study of atherosclerosis, RMT1-10 could specifically expand TIM1+ IgM+ B1a cells and reduce the number of CD4+ CD8+ T cells, thereby reducing arterial inflammation and inhibiting the progression and development of atherosclerosis [14].